Rutgers infectious disease expert Shobha Swaminathan is available to discuss the mixing and matching of COVID-19 vaccines and boosters as the Food and Drugs Administration authorized booster shots for both the Johnson & Johnson and Moderna vaccines.
“There is mounting evidence to suggest that mixing and matching of vaccines or heterologous boosting probably elicits higher antibody responses than getting a booster with the same vaccine as your primary series or homologous boosting,” said Swaminathan, associate professor at Rutgers New Jersey Medical School and the principal investigator for the Moderna phase 3 clinical trial at Rutgers. “This is particularly true if you had previously received a vector vaccine such as the J&J or the AstraZeneca vaccine and were then boosted by one of the two mRNA vaccines.”
Rutgers Biomedical and Health Sciences (RBHS) takes an integrated approach to educating students, providing clinical care and conducting research, all with the goal of improving human health. Aligned with Rutgers University–New Brunswick, and collaborating university-wide, RBHS includes eight schools, a behavioral health network and four centers and institutes. RBHS offers an outstanding education in medicine, dentistry, pharmacy, public health, nursing, biomedical research and the full spectrum of allied health careers. RBHS clinical and academic facilities are located throughout the state.